Navigation Links
Asymptomatic HIV babies could use earlier treatment

ng antiretroviral treatment are not known. Concerns about the drugs?possible toxic side-effects and the development of viral resistance to available treatments must be balanced against a desire to do everything possible to keep infected children healthy.

Maldonado and her colleagues collected data from hospitals throughout northern California over a 17- year period. Statistical calculations indicate that their sample of 205 children represent nearly every HIV-infected child born in the area during that time—an unbiased sample that allowed them to analyze all infected babies, not just the sickest. “We were able to analyze children with the full spectrum of disease across many years, rather than using mathematical models to predict the development of illness in the children,?said Maldonado. “We were able to see the real distribution of illness, what kinds of treatment the children were given and the ages when they started treatment.?/p>

The researchers divided the HIV-infected newborns into three groups: those born from 1988 to 1991, from 1992 to 1995 and from 1996 to 2001 based on the types of therapy available in those years. Members of the early group were usually evaluated for infection by their first birthday; those in the middle and late groups were assessed within the first month. Those in the late group benefited from the introduction of a special type of antiretroviral drug called a protease inhibitor. They followed the children for the first three years of life, tracking at what age they developed AIDS and the rate of survival through their third birthday.

As might be expected, infants born later in the study period were more likely to receive triple therapy and less likely to experience AIDS-related complications or death. In fact, none of the 23 children who received triple therapy died or developed AIDS before their third birthday. In contrast, about 55 percent of the children in the first two groups died of AIDS. When the researchers
'"/>

Source:Stanford University


Page: 1 2 3

Related biology news :

1. OHSU research shows vitamin C counteracts some negative impacts of smoking on unborn babies
2. New brain scan technology could save babies lives
3. New tool tracks brain development in babies
4. Todays babies are fatter babies
5. Research offers new hope for preterm babies
6. Hair samples show babies can be exposed to crystal meth while in the womb
7. Solvent exposure linked to birth defects in babies of male painters
8. Designer babies - what would you do for a healthy baby?
9. Why do cold animals make bigger babies?
10. A revolution in the monitoring of unborn babies
11. Thymus transplants gives hope to babies with fatal immune disease
Post Your Comments:
(Date:12/16/2009)... HARBOR, Fla., Dec. 2 Communication ... a leading supplier of electronic signature solutions ... industry* and the recognized leader** in biometric ... a leading International Electronic Document Management (EDM) ... entered an agreement to provide their products ...
(Date:12/16/2009)... CHURCH, Va., Dec. 9 CSC ... that the American Association for Laboratory Accreditation ... Commission (ISO/IEC) 17025:2005 accreditation to the company,s ... CSC Identity Labs located in Fairmont, W.Va. ... test laboratory in the world to achieve ...
(Date:12/15/2009)... signed an agreement with the British Society for Research ... the journal Biogerontology for an initial period ... member of the Biogerontology editorial board and ... Springer will sponsor the society and provide society members ... www.springerlink.com . , Biogerontology offers a ...
Breaking Biology News(10 mins):CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 2CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 3CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 4CSC's Identity Management and Biometric Test Lab Achieves ISO/IEC 17025 Accreditation 2Greenway Medical Technologies Plays Leading Role in Interoperability Demonstrations at Seventh Annual Public Health Information Network 28PHIN 29 Con 13987 1Greenway Medical Technologies Plays Leading Role in Interoperability Demonstrations at Seventh Annual Public Health Information Network 28PHIN 29 Con 13987 2Greenway Medical Technologies Plays Leading Role in Interoperability Demonstrations at Seventh Annual Public Health Information Network 28PHIN 29 Con 13987 3Greenway Medical Technologies Plays Leading Role in Interoperability Demonstrations at Seventh Annual Public Health Information Network 28PHIN 29 Con 13987 4MultiVu Video Feed 3A POSITIVE PHASE 3 TRIAL DATA FOR INVESTIGATIONAL NEW MIGRAINE TREATMENT PRESENTED IN LATE BREAKING SESSION AT 14th ANNUAL INTERNA 4962 1MultiVu Video Feed 3A POSITIVE PHASE 3 TRIAL DATA FOR INVESTIGATIONAL NEW MIGRAINE TREATMENT PRESENTED IN LATE BREAKING SESSION AT 14th ANNUAL INTERNA 4962 2Replication at DNA damage sites highlights Fanconi anemia and breast cancer proteins 56805 1Replication at DNA damage sites highlights Fanconi anemia and breast cancer proteins 56805 2
... leading study that has implications for the development of ... ovarian cancers that have lost the expression of a ... the loss of the GPC3 gene induces overgrowth through ... cancer growth. , Published today in Developmental Cell, the ...
... May 12, 2008 There exists much ethical controversy brought ... to religion. In a new essay in The Journal of ... medical ethics that draws upon Jewish texts, traditions, and philosophy ... of this faith tradition. , Genetic explanations for how ...
... new project (RevGenUK) is being launched at the John Innes ... , This knowledge can be used to improve the ... grow more sustainably with reduced nitrogen fertilisers. , ... and Biological Sciences Research Council (BBSRC), the project builds on ...
Other Biology News:Religion and the narrative of biological science 2
(Date:12/15/2009)... Joint BioEnergy Institute (JBEI), one of three Department of ... trusted time-stamping service to protect its valuable intellectual property. ... ... VA (PRWEB) December 15, 2009 -- Surety, LLC ... solutions , today announced that the Joint BioEnergy Institute ...
(Date:12/15/2009)... and CHARLOTTESVILLE, Va., Dec. 15 ... the University of Virginia (UVa) in Charlottesville, ... a strategic research collaboration to enhance development ... disease (CAD) with a secondary focus on ... http://www.newscom.com/cgi-bin/prnh/20091027/PH99766LOGO ) ,, The collaborative preclinical ...
(Date:12/15/2009)... -- On January 20th, 2010, the inaugural European ... Professionals (ISMPP) will be held at the Royal ... 100 attendees are expected at this prestigious event, ... publishers, medical writers and medical agencies to discuss ... impact of guidelines and regulations such as GPP-2, ...
(Date:12/14/2009)... Dec. 14 Vermillion, Inc. (Pink ... announced William C. Wallen, Ph.D. Chief Scientific ... for IDEXX Laboratories, will be joining its ... bankruptcy plan. ,, "Bill brings more ... in diagnostics and biotechnology," said Gail Page, ...
Breaking Biology Technology:Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 2Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 3Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 4Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 5AstraZeneca and the University of Virginia Sign Strategic Research Collaboration to Develop Novel Treatments for Cardiovascular Disease 2AstraZeneca and the University of Virginia Sign Strategic Research Collaboration to Develop Novel Treatments for Cardiovascular Disease 3Announcing ISMPP EU 2010 - the First European Meeting of the International Society for Medical Publication Professionals, Royal College of Physicians, London, UK, January 20, 2010 2Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 2Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 3Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 4
... WHO and CDC have stated that the,predictive accuracy ... -- often correct less than 50% of the time,especially ... yet accurate in,our predictions of upcoming influenza strains, approximately ... States alone., As in the case of hurricanes, ...
... (Nasdaq: TPTX ) today announced financial results for ... period, the Company posted,revenue of $1.2 million and a ... $14.3 million at September 30, 2008., "The past ... transition to a development-only company," said Ev Graham, acting ...
... /Xinhua-PRNewswire-FirstCall/ -- China Shenghuo,Pharmaceutical Holdings, Inc. (Amex: ... which is engaged in the research, development, ... cosmetic products,in the People,s Republic of China, ... (formerly the American Stock Exchange) (the "Exchange") ...
Other Biology Technology:A New Way to Predict Outbreaks: Replikin Peptide Concentration in H5N1 Influenza Virus Genome as a Marker for Lethal Outbreaks 2A New Way to Predict Outbreaks: Replikin Peptide Concentration in H5N1 Influenza Virus Genome as a Marker for Lethal Outbreaks 3TorreyPines Therapeutics Reports Third Quarter 2008 Results and Recent Accomplishments 2TorreyPines Therapeutics Reports Third Quarter 2008 Results and Recent Accomplishments 3TorreyPines Therapeutics Reports Third Quarter 2008 Results and Recent Accomplishments 4TorreyPines Therapeutics Reports Third Quarter 2008 Results and Recent Accomplishments 5TorreyPines Therapeutics Reports Third Quarter 2008 Results and Recent Accomplishments 6TorreyPines Therapeutics Reports Third Quarter 2008 Results and Recent Accomplishments 7NYSE Alternext US Accepts China Shenghuo's Compliance Plan for Continued Listing 2NYSE Alternext US Accepts China Shenghuo's Compliance Plan for Continued Listing 3NYSE Alternext US Accepts China Shenghuo's Compliance Plan for Continued Listing 4
... These handy dispensers save space and ... and other garb. They are the ... parts used in labs, processing and ... charges and the particles they attract. ...
... 2 NaO 7 S 2 Formula Weight: ... Identity: By IR epsilon max (615 nm, ... equal to 60 x 10 3 Loss ... lambda max (H 2 O solution): ...
...
... FP-6500 is the research-grade spectrofluorometer with a ... sensitivity S/N ratio 200 or greater for ... is especially designed to keep in mind ... as kinetics, stopped-flow, titration, or anisotropic measurements. ...
Biology Products: